Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial
2022 · The Lancet. Gastroenterology & hepatology · 157 citations
https://doi.org/10.1016/s2468-1253(22)00093-0
R
Reha Artan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
115
Papers
1.3K
Citations
19
h-index
32
i10-index
Reha Artan is an academic researcher from Akdeniz University. The author has contributed to research in topics: Helicobacter pylori-related gastroenterology studies & Liver Disease Diagnosis and Treatment & Drug Transport and Resistance Mechanisms. The author has an h-index of 19, co-authored 98 publications.
ORCID: 0000-0001-6114-9210Papers by this author
worksInterim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis
2023 · JHEP Reports · 28 citations
https://doi.org/10.1016/j.jhepr.2023.100782
Extremely rare cause of congenital diarrhea: Enteric anendocrinosis
2013 · Pediatrics International · 20 citations
https://doi.org/10.1111/ped.12169
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat